volume 14 issue 12 pages 4067-4077

Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.

Publication typeJournal Article
Publication date2006-06-01
scimago Q2
wos Q1
SJR0.608
CiteScore6.7
Impact factor3.0
ISSN09680896, 14643391
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
Novel combretastatin analogues bearing various five-membered heterocycles with consecutive oxygen and nitrogen atoms, in place of the olefinic bridge of CA4, have been synthesized (isoxazole, isoxazoline, oxadiazole, etc). These compounds have been evaluated for cytotoxicity and their ability to inhibit the tubulin assembly. On the basis of the relative position of the aromatic A- and B-rings on the heterocyclic moiety, they could be split in two classes, the alpha,gamma- or alpha,beta-diaryl heterocyclic derivatives. In the first series, the 3,5-diaryloxadiazole 9a displayed comparable antitubulin activity to that of CA4, but was devoid of cytotoxic effects. Among the alpha,beta-diaryl heterocyclic derivatives, the 4,5-diarylisoxazole 35 exhibited greater antitubulin activity than that of CA4 (0.75 vs 1.2 microM), but modest antiproliferative activity. These data showed that minor alteration in the chemical structure of the heterocyclic ring and its relative orientation with regard to the two phenyl rings of CA4 could dramatically influence the tubulin binding properties.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
European Journal of Medicinal Chemistry
14 publications, 11.86%
European Journal of Organic Chemistry
7 publications, 5.93%
Tetrahedron
5 publications, 4.24%
Bioorganic and Medicinal Chemistry
5 publications, 4.24%
Bioorganic and Medicinal Chemistry Letters
4 publications, 3.39%
Mendeleev Communications
4 publications, 3.39%
Journal of Heterocyclic Chemistry
4 publications, 3.39%
Medicinal Chemistry Research
3 publications, 2.54%
Russian Chemical Bulletin
3 publications, 2.54%
Tetrahedron Letters
3 publications, 2.54%
ChemistrySelect
3 publications, 2.54%
Journal of Medicinal Chemistry
3 publications, 2.54%
MedChemComm
3 publications, 2.54%
Chemistry of Heterocyclic Compounds
2 publications, 1.69%
Journal of Molecular Structure
2 publications, 1.69%
Archiv der Pharmazie
2 publications, 1.69%
Heteroatom Chemistry
2 publications, 1.69%
Organic Letters
2 publications, 1.69%
Journal of Organic Chemistry
2 publications, 1.69%
ACS Combinatorial Science
2 publications, 1.69%
New Journal of Chemistry
2 publications, 1.69%
Drug Research
2 publications, 1.69%
Synlett
2 publications, 1.69%
Russian Chemical Reviews
1 publication, 0.85%
Journal of Pharmacology and Experimental Therapeutics
1 publication, 0.85%
Letters in Organic Chemistry
1 publication, 0.85%
Journal of Theoretical and Computational Chemistry
1 publication, 0.85%
Molecules
1 publication, 0.85%
International Journal of Molecular Sciences
1 publication, 0.85%
2
4
6
8
10
12
14

Publishers

5
10
15
20
25
30
35
40
45
Elsevier
43 publications, 36.44%
Wiley
23 publications, 19.49%
Springer Nature
12 publications, 10.17%
American Chemical Society (ACS)
10 publications, 8.47%
Royal Society of Chemistry (RSC)
9 publications, 7.63%
Georg Thieme Verlag KG
5 publications, 4.24%
Taylor & Francis
4 publications, 3.39%
MDPI
2 publications, 1.69%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.85%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.85%
Bentham Science Publishers Ltd.
1 publication, 0.85%
World Scientific
1 publication, 0.85%
Public Library of Science (PLoS)
1 publication, 0.85%
Pleiades Publishing
1 publication, 0.85%
Japan Society for Analytical Chemistry
1 publication, 0.85%
Walter de Gruyter
1 publication, 0.85%
Hindawi Limited
1 publication, 0.85%
AIP Publishing
1 publication, 0.85%
5
10
15
20
25
30
35
40
45
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
118
Share
Cite this
GOST |
Cite this
GOST Copy
Kaffy J. et al. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation. // Bioorganic and Medicinal Chemistry. 2006. Vol. 14. No. 12. pp. 4067-4077.
GOST all authors (up to 50) Copy
Kaffy J., Pontikis R., Carrez D., Croisy A., Monneret C., Florent J. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation. // Bioorganic and Medicinal Chemistry. 2006. Vol. 14. No. 12. pp. 4067-4077.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bmc.2006.02.001
UR - https://doi.org/10.1016/j.bmc.2006.02.001
TI - Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.
T2 - Bioorganic and Medicinal Chemistry
AU - Kaffy, Julia
AU - Pontikis, Renée
AU - Carrez, Danièle
AU - Croisy, Alain
AU - Monneret, Claude
AU - Florent, Jean-Claude
PY - 2006
DA - 2006/06/01
PB - Elsevier
SP - 4067-4077
IS - 12
VL - 14
PMID - 16510288
SN - 0968-0896
SN - 1464-3391
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2006_Kaffy,
author = {Julia Kaffy and Renée Pontikis and Danièle Carrez and Alain Croisy and Claude Monneret and Jean-Claude Florent},
title = {Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.},
journal = {Bioorganic and Medicinal Chemistry},
year = {2006},
volume = {14},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016/j.bmc.2006.02.001},
number = {12},
pages = {4067--4077},
doi = {10.1016/j.bmc.2006.02.001}
}
MLA
Cite this
MLA Copy
Kaffy, Julia, et al. “Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation..” Bioorganic and Medicinal Chemistry, vol. 14, no. 12, Jun. 2006, pp. 4067-4077. https://doi.org/10.1016/j.bmc.2006.02.001.